904 related articles for article (PubMed ID: 2428652)
1. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
2. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte function-associated antigen (LFA-1) is involved in B cell activation.
Howard DR; Eaves AC; Takei F
J Immunol; 1986 Jun; 136(11):4013-8. PubMed ID: 2422269
[TBL] [Abstract][Full Text] [Related]
4. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
5. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
[TBL] [Abstract][Full Text] [Related]
6. Differential MHC class II expression on human peripheral blood monocytes and dendritic cells.
Brooks CF; Moore M
Immunology; 1988 Feb; 63(2):303-11. PubMed ID: 3350576
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
8. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
Clement LT; Tedder TF; Gartland GL
J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
Klohe EP; Watts R; Bahl M; Alber C; Yu WY; Anderson R; Silver J; Gregersen PK; Karr RW
J Immunol; 1988 Sep; 141(6):2158-64. PubMed ID: 2459201
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
Pesando JM; Graf L
J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
[TBL] [Abstract][Full Text] [Related]
11. Possible T4-HLA class II interaction as an essential event in antigen-specific helper T lymphocyte-dependent B cell activation.
Fischer A; Sterkers G; Charron D; Durandy A
Eur J Immunol; 1986 Sep; 16(9):1111-6. PubMed ID: 2944748
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
[TBL] [Abstract][Full Text] [Related]
13. Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements.
Merkenschlager M; Ikeda H; Wilkinson D; Beverly PC; Trowsdale J; Fisher AG; Altmann DM
Eur J Immunol; 1991 Jan; 21(1):79-88. PubMed ID: 1671359
[TBL] [Abstract][Full Text] [Related]
14. T cell alloresponses against HLA-DQ and -DR products involve multiple epitopes on the CD4 molecule. Distinct mechanisms contribute to the inhibition of HLA class II-dependent and -independent T cell responses by antibodies to CD4.
Merkenschlager M; Altmann DM; Ikeda H
J Immunol; 1990 Nov; 145(10):3181-7. PubMed ID: 1699999
[TBL] [Abstract][Full Text] [Related]
15. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
16. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
[TBL] [Abstract][Full Text] [Related]
17. T cells specific for different antigens express different HLA-D region products.
Schendel DJ; Johnson JP
Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
Guerry D; Alexander MA; Elder DE; Herlyn MF
J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
[TBL] [Abstract][Full Text] [Related]
19. Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigens.
Holte H; Blomhoff HK; Beiske K; Funderud S; Torjesen P; Gaudernack G; Stokke T; Smeland EB
Eur J Immunol; 1989 Jul; 19(7):1221-5. PubMed ID: 2547623
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a monoclonal antibody recognizing a monomorphic determinant of DR antigens.
Schütt C; Horejsi V; Walzel H; Siegl E
Biomed Biochim Acta; 1989; 48(4):359-63. PubMed ID: 2473743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
